Acrivon Therapeutics Inc (ACRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 1,583 | N/A |
| TOTAL | $1,719 | $N/A |
| Non-Current Assets | ||
| PPE Net | 59 | N/A |
| Other Non-Current Assets | 407 | 0 |
| TOTAL | $466 | $N/A |
| Total Assets | $2,185 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 136 | 0 |
| Accrued Expenses | 477 | N/A |
| TOTAL | $613 | $N/A |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 318 | 0 |
| TOTAL | $318 | $N/A |
| Total Liabilities | $931 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 1 | N/A |
| Retained earnings | -8,622 | N/A |
| Other shareholders' equity | 9,667 | 0 |
| TOTAL | $1,254 | $N/A |
| Total Liabilities And Equity | $2,185 | $0 |